Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300384
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,264
Award facts
- Contract value 100% obligated
- $3,263.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
About this award
This contract award represents a Blanket Purchase Agreement (BPA) call issued by the Office of the Director, a civilian federal agency, to Lonza Walkersville, Inc. for the procurement of drugs and biologicals. The contract, valued at $3,263.52 with a firm fixed price structure, was awarded on November 14, 2013, with an ultimate completion date of December 31, 2013. The work will be performed at Lonza Walkersville's facility in Walkersville, Maryland. This award did not utilize a set-aside designation, indicating open competition in the procurement process. Lonza Walkersville, Inc., a subsidiary of the global Lonza Group and a foreign-owned manufacturer of biological materials and laboratory equipment, has been registered in the System for Award Management (SAM.gov) since 2002.
This call order is issued under Lonza Walkersville's larger $10 million single-award BPA with the Health and Human Services (HHS) Office of Logistics and Acquisition Operations, which remains valid through December 31, 2025. The BPA framework enables streamlined procurement of biological materials, blood products, media products, laboratory supplies, and medical and scientific equipment to support research initiatives across multiple National Institutes of Health (NIH) institutes and research centers. Lonza Walkersville has established itself as a critical supplier to federal biomedical and life sciences research institutions, consistently delivering specialized research equipment and biological materials for studies in cancer research, infectious diseases, regenerative medicine, and cellular engineering.
Quick answers
Who was awarded contract HHSN26300384?
HHSN26300384 was awarded to Lonza Walkersville, Inc. by Office of the Director (National Institutes of Health) on November 14, 2013.
How much is contract HHSN26300384 worth?
The government has obligated $3,264 on HHSN26300384.
Is contract HHSN26300384 an order under another contract?
Yes. HHSN26300384 is a BPA call under HHSN263199900049886B, a blanket purchase agreement.
Was contract HHSN26300384 competed?
The extent of competition for HHSN26300384 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award